3Kulkarni K,Marwaha RK. Pattern and determinants of central nervous system relapse in childhood acute lymphoblastic leukemia in a resource-limited setting[J].Indian J Med Paediatr Oncol,2013,(01):48-49.
4Asai D,Imamura T,Suenobu S. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan[J].Cancer Med,2013,(03):412-419.
5Mansour MR,Sanda T,Lawton LN. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia[J].{H}Journal of Experimental Medicine,2013,(08):1545-1557.
6Isakoff MS,Freyer DR,Bleyer A. Young adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen do not need a bone marrow transplant in first remission[J].{H}Blood,2013,(26):5253-5255.
7Buyukasik Y,Acar K,Kelkitli E. Hyper-CVAD regimen in routine management of adult acute lymphoblastic leukemia:a retrospective multicenter study[J].{H}ACTA HAEMATOLOGICA,2013,(03):199-205.
8Mateos MK,OBrien TA,Oswald C. Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia:25-year retrospective review[J].{H}PEDIATRIC BLOOD & CANCER,2013,(09):1520-1527.
9Keating GM. A guide to its use in acute lymphoblastic leukemia in the USA[J].Biol Drugs,2013,(04):413.
10Gaynon PS, Angiolillo AL, Carroll WL, et ah Long-term re- sults of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Chihtren' s Ontology Group report [ J ]. Leukemia, 2010,24(2) : 285-297.
